Lawson Health Research Institute

Researchers at Lawson and Western University have found a new brain imaging technique appears to be able to detect whether patients who are unresponsive following a severe brain injury can feel pain, hear their surroundings and retain conscious awareness. The team used functional near infrared spectroscopy (fNIRS), a portable brain imaging technique, to learn whether patients that appear to be in a coma in the ICU had preserved consciousness by recording brain activity at their bedside. London Health Sciences Centre (LHSC)

Join London Health Sciences Centre (LHSC) and St. Joseph's Health Care London on October 16 as we launch the future of health research in London! Get an up-close look at exciting breakthroughs and get hands-on experience with new, London-based health technologies that have the potential to change the world. Come meet some of the brightest minds in health research in a rare behind-the-scenes view of work they do to make an impact in the lives of patients at home and around the globe. Learn more: https://lnkd.in/gppJCPDU

In the first Canadian study of its kind, Dr. Cheryl Forchuk is working with partners across the country to study #homelessness among women who are #veterans. More than just a census, the study examines obstacles and solutions that may be unique to women veterans experiencing homelessness. The $1.2M grant from Housing, Infrastructure and Communities Canada | Logement, Infrastructures et Collectivités Canada will help ensure veterans have the support they need. St. Joseph's Health Care London The Royal Canadian Legion https://lnkd.in/gynp7_xS

Congratulations to our Dr. Richard Kim at London Health Sciences Centre (LHSC) for this support of his work to reduce the side effects of kinase inhibitors used to treat multiple types of cancer.

On October 16, we’re launching the future of health research in London – and you won’t want to miss it! Join us as we transition from Lawson Health Research Institute and strengthen research through two future-focused, innovative research institutes at St. Joseph's Health Care London and London Health Sciences Centre (LHSC). More details to come on the events of Oct. 16, and the exciting work that will follow.

Two world first discoveries from London Health Sciences Centre (LHSC) and Lawson Health Research Institute allow for accurate diagnosis of rare diseases and those that have been caused by environmental factors rather than genetics. In one of two newly published studies, Dr. Sadikovic found EpiSign™, a technology he developed, can be used to accurately identify patients affected by birth disorders called recurrent constellation of embryonic malformations (RCEMs). Since their discovery more than 70 years ago, it has been challenging to provide patients and families with accurate diagnoses. EpiSign can now be used to accurately identify RCEMs for the first time using a blood test.  In a second study, Dr. Sadikovic’s team used EpiSign technology for the first time to develop an accurate biomarker for a group of disorders called fetal valproate syndrome, which is caused by prenatal exposure to toxic levels of medication and can result in neurodevelopmental disorders in infants.   Read more on these significant breakthrough studies: https://lnkd.in/gpuUkuAb

Some fascinating research is happening involving neuroimaging and brain injury.

This partnership is also having a great impact on research!

Congratulations to London Health Sciences Centre (LHSC)'s Dr. Mark Vincent and St. Joseph's Health Care London's Dr. Lisa Porter on this great news!

Some incredible #research stories were highlighted in London Health Sciences Centre (LHSC)'s annual report, including harm reduction research to improve care and new technology to diagnose rare diseases.